Tariffs can have complex consequences for medical products as essential as facemasks, gloves and gowns. It is critical to keep public and private stakeholders fully informed on potential impacts to the healthcare supply chain. Check out the key industry advocacy actions since 2018 that HIDA and its member companies have led and championed.
HIDA comments opposed tariffs. Multiple testimonies before USTR.
Promoted Sen. Portman letter which called for exemption of gloves and gowns.
Expressed concerns via additional comments and testimony.
Urged USTR to exempt gloves and gowns from tariffs.
Discussed preparedness issues with HHS.
Requested USTR to extend tariff exclusions.
Emphasized impact on distributors to HHS.
Congressional letter supporting tariff exclusion for critical medical supplies.
Weighed-in on USTR’s 4-year review process.
Comments opposed tariffs and medical device increases.
Facemasks tariff increased 25%.
Syringes and needles increased 100%.
Medical gloves set to increase 50% on January 1, 2025.
Facemasks tariff expected to increase 50%.
Medical gloves expected to increase 100%.